News and Trends 2 Nov 2022
Meletios Therapeutics wins €5.2M European Commission funding for SARS research
Meletios Therapeutics, a French biotech company, announced today (November 2) that it has been named one of 75 winners of the European Innovation Council (EIC) Accelerator program and will receive…